SYNTHETIC BIOLOGY - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Synthetic Biology in US$ Thousand by the following Application Areas: Energy & Chemicals, Biotechnology & Pharmaceuticals, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 38 companies including many key and niche players such as -

Amyris Biotechnologies, Inc.
ATG Biosynthetics GmbH
BP Plc
Chromatin Inc.
GenScript USA, Inc.


Click here to request a full list of companies covered in the report...

Code: MCP-6581
Price: $4500
Companies: 38
Pages: 155
Date: November 2013
Market Data Tables: 37

Complimentary Market Brief:


Request a Complimentary Copy of the Report Insights, Key Findings, Drivers, Trends, Program Sources, and Methodology.
Salutation:
First Name:
Last Name:
Email ID: (Domain Specific Email Required)
Company:
NOTE: Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSN etc. cannot be used

 TABLE OF CONTENTS


 
   Study Reliability And Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definitions And Scope Of Study.....I-3
  
   A Quick Primer.....II-1
Synthetic Biology: Prediction Becoming Reality.....II-1
1$100
   Current & Future Analysis.....II-21$100
   Growth Drivers.....II-3
Major Concerns.....II-3
1$100
   Future Outlook.....II-4
Synthetic Biology – An Emerging Discipline.....II-4
1$100
   Contribution of Synthetic Biology to Biotech.....II-5
Craig Venter’s Synthetic Life: Momentous Achievement in Synthetic Biology
  Field.....II-5
Gibson Assembly®: Building Toolset for Synthetic Biology.....II-5
1$100
   Gen9’s BioFab: Major Breakthrough in Synthetic Biology.....II-6
Key Developments in the Synthetic Biology Field.....II-6
2$200
   Synthetic Biology Products with Commercial Potential in the Future.....II-82$200
   Is Synthetic Biology a Bane or Boon?.....II-10
Synthetic Biology Exhibits Plateau in Awareness.....II-10
Synthetic Biology Research Gathers Momentum.....II-10
1$100
   US and Europe - Propelling Research in the Field of Synthetic Biology.....II-11
Table 1: Number of Entities Focused on Synthetic Biology Research Globally: 2009 & 2013 (includes corresponding Graph/Chart).....II-11
1$350
   Table 2: Synthetic Biology and their Potential Areas of Applications Being Researched by Biological Systems Manufacturers/Designers (includes corresponding Graph/Chart).....II-121$350
   Table 3: Number of Biological Systems Manufacturers/Designers Focused on Specialty/ Fine Chemical Applications (includes corresponding Graph/Chart).....II-131$350
   Synthetic Biology Mired by Challenges in Developing Countries.....II-14
Systems Biology Leading to Advancements in Synthetic Biology.....II-14
Food and Other Basic Needs’ Scarcity to Fuel Synthetic Biology Market.....II-14
1$100
   Food, Water, and Energy Statistics.....II-15
Do-It-Yourself Biology (DIYBio): A Growing Phenomenon.....II-15
Synthetic Biology Gaining Prominence in Biomedical Applications.....II-15
1$100
   Research Efforts in Full Swing to Treat Life-Threatening Diseases using Synthetic
  Biology.....II-16
1$100
   Synthetic Biology Therapeutics to Address Antibiotic-Resistance Crisis.....II-171$100
   Pipeline Perspective of Synthetic Biology Therapeutics (Synthetic Biologics and
  Intrexon Collaboration).....II-18
Synthetic Biology for Wildlife Conservation Laden with Risks.....II-18
Synthetic Biology Gains Significance in Production of Biofuels.....II-18
1$100
   Synthetic Biology for Energy Supply: Potential Threat to Biodiversity.....II-19
Lack of Regulatory Framework: A Major Cause of Concern.....II-19
2$200
   Introduction.....II-21
Historical Background.....II-21
Synthetic Biology Vis-à-vis Genetic Engineering - A Comparison.....II-21
1$100
   Scope of Synthetic Biology in Various Fields.....II-22
Engineering.....II-22
Chemistry.....II-22
Major Enabling Technologies.....II-22
Sequencing.....II-22
1$100
   Fabrication.....II-23
Modeling.....II-23
Measurement.....II-23
Market Potential.....II-23
Pharmaceutical.....II-23
Industrial.....II-23
Agriculture.....II-23
Life Sciences Research.....II-23
Renewable Energy.....II-23
Potential Uses.....II-23
1$100
   Biomedicine.....II-24
Intricate Molecular Devices Utilized for Tissue Regeneration/Repair.....II-24
Smart Drugs.....II-24
Biological Delivery Systems.....II-24
Vectors for Therapy.....II-24
Personalized Medicine.....II-24
1$100
   Cells with Novel Properties for Betterment of Human Health.....II-25
In Vivo Synthesis of Small-Molecule Pharmaceuticals.....II-25
Intricate Natural Products.....II-25
Expansion of Chemistry of Life.....II-25
Expanding Genetic Alphabet.....II-25
Nucleic Acids.....II-25
1$100
   Proteins.....II-26
New Imaging and Targeting Methods.....II-26
Chemical Industry Sustainability.....II-26
Eco-friendly Production of Chemicals.....II-26
Energy and Environment.....II-26
Bioremediation.....II-26
Energy Production.....II-26
1$100
   Biomaterials and Smart Materials Production.....II-27
Synthesis.....II-27
Organization.....II-27
Socio-Economic Concerns and Risks of Synthetic Biology.....II-27
Production of Bio-Weapons.....II-27
Accidental Release.....II-27
Return on Investment.....II-27
1$100
   Dissonance with Other Disciplines.....II-28
Continuous Evolution.....II-28
Curtailed Understanding.....II-28
Unpredictable Ecosystem Effects.....II-28
Unexpected Transfer of Genes.....II-28
Aggravating Problems.....II-28
1$100
   Industry Associations.....II-29
Synthetic Biology Industry Association (SynBIA).....II-29
Industry Association of Synthetic Biology (IASB).....II-29
1$100
   Synthetic Biology In Repelling Viruses.....II-30
Synthetic Biology in Engineered Food.....II-30
Synthetic Biology to Address Issues Related to Algal Blooms.....II-30
Synthetic Biology Holds Potential for Testing Water Purity.....II-30
Mars – A Home Away from Home Courtesy Synthetic Biology.....II-30
Predictable Biological Systems - No More a Myth.....II-30
1$100
   Researchers at JCVI Make Novel Advances in Synthetic Genomics.....II-31
Synthetic Biology Tools Can Detect Listeria Contamination in Food Products.....II-31
1$100
   Synthetic Biology Accelerates Flu Vaccine Production.....II-32
Bioengineers at Duke University Develops Novel System for Reproducing Natural Complex
  Gene Regulation.....II-32
1$100
   TALE: A Viable Technology for Synthetic Protein Development.....II-33
Can Synthetic Biology Fuel Cars or Household Power Supplies Using Naturally-Existing
  Fatty Acids?.....II-33
Researchers Engineered Synthetic Compound to Defend Iron Deficiency.....II-33
Cellular Circuit Designing Made Possible through Biological Genes.....II-33
1$100
   Meshing Inputs/Outputs Offer Layered Circuits.....II-34
Cambrian Genomics Pioneers DNA Laser Printer.....II-34
Researchers Develop Novel Technique that Speeds the Process for Developing New
  Biological Parts.....II-34
1$100
   Researchers Develop Novel Biological Device that Mimics Transistor-Like
  Properties.....II-35
1$100
   Life Technologies Unveils Vector NTI® Express Designer Bioinformatics Software
  Platform.....II-36
Gen9 Introduces GeneBytesTM DNA Constructs.....II-36
1$100
   New England Biolabs and Synthetic Genomics Launches Gibson Assembly Cloning Kit and
  NEBuilderTM Primer Design Tool.....II-37
GenScript Introduces Gene-Brick™ Gene Synthesis Service.....II-37
1$100
   DNA2.0 Successfully Integrates SBOL into Gene Designer Biological Design Tool.....II-38
454 Life Sciences to Introduce GS Junior System and Improve Genome Sequencer FLX
  System.....II-38
1$100
   DNA2.0 Launches pJexpress.....II-39
febit Introduces miRBase 14.0-based miRNA Biochip.....II-39
Codexis Launches Codex™ MicroCyp Plate.....II-39
GeneWorks Expands Genome Analysis Services.....II-39
1$100
   Sanofi Commences Large-Scale Production of Semi-Synthetic Artemisinin.....II-40
EVOLVA and IFF Enter into Pre-Manufacturing Phase for Natural Vanillin.....II-40
Synthetic Genomics Enters into Research Agreement with ExxonMobil.....II-40
1$100
   Amyris Signs Long Term Agreement with International Flavors & Fragrances.....II-41
SGI-DNA and IDT Announce Expanded Collaboration.....II-41
1$100
   College of Engineering Establishes BU Center of Synthetic Biology.....II-42
Gen9 Enters into Partnership with Agilent Technologies.....II-42
1$100
   AquaBounty Technologies Enters into Exclusive Channel Collaboration with
  Intrexon.....II-43
Synthetic Biologics Collaborates with Intrexon for Infectious Disease
  Therapies.....II-43
1$100
   DuPont Collaborates with OligoCo.....II-44
DNA2.0 Collaborates with Newcastle University.....II-44
1$100
   Amyris Secures Contract from the US DARPA.....II-45
Pfenex Collaborates with DNA2.0.....II-45
Synthetic Genomics Inks Agreement with New England Biolabs.....II-45
1$100
   Amyris Commences Production of Biofene in Brazil.....II-46
Amyris Takes Over Draths.....II-46
Intrexon Collaborates with Adeona Pharmaceuticals for PAH Therapy.....II-46
1$100
   febit biomed Changes Name to Comprehensive Biomarker Center.....II-47
Life Technologies Inks Exclusive License Agreement with the Inventors of TAL Effector
  Technology.....II-47
1$100
   Amyris Inks Agreement with Givaudan.....II-48
LS9 Expands Strategic Partnership with P&G.....II-48
Amyris Commissions Industry-Scale Production of Biofene®.....II-48
1$100
   Intrexon Establishes Cell Engineering Unit in California.....II-49
Halozyme Enters into Exclusive Worldwide Licensing Agreement with Intrexon.....II-49
1$100
   Evozym Biologics Forms Strategic Business Alliance and Collaboration with
  GenScript.....II-50
Intrexon Takes Over Neugenesis.....II-50
1$100
   ZIOPHARM Oncology Enters into Partnership with Intrexon.....II-51
Amyris Brasil Inks Agreements with Acucar Guarani, Bunge and Cosan Group.....II-51
1$100
   Amyris Brasil Inaugurates Demonstration Facility.....II-52
Amyris Biotechnologies to Acquire Stake in Boa Vista Mill from São Martinho
  Group.....II-52
Synthetic Genomics Inks Agreement with ExxonMobil Research and Engineering
  Company.....II-52
1$100
   Verdezyne Inks Agreement with Novozymes.....II-53
Verdezyne Collaborates with Genencor.....II-53
OneWorld Health, Sanofi-aventis and Amyris Biotechnologies Enter into
  Partnership.....II-53
1$100
   Amyris Biotechnologies Enters into Partnership with Crystalsev.....II-54
GENEART Extends Partnership with QIAGEN.....II-54
1$100
   LC Sciences and DNAVision Enter into Strategic Marketing Alliance.....II-551$100
   Players Focused on Synthetic Biology Applications Amyris Biotechnologies, Inc.
  (US).....II-56
BP PLC. (UK).....II-56
1$100
   Chromatin Inc. (US).....II-57
E. I. du Pont de Nemours and Company (US).....II-57
1$100
   Evolva SA (Switzerland).....II-58
Gevo, Inc. (US).....II-58
1$100
   Joule Unlimited, Inc. (US).....II-59
LS9, Inc. (US).....II-59
Metabolix (US).....II-59
MorphoSys AG (Germany).....II-59
1$100
   Sapphire Energy, Inc. (US).....II-60
Solazyme, Inc. (US).....II-60
Synthetic Biologics, Inc. (US).....II-60
Synthetic Genomics, Inc. (US).....II-60
1$100
   Players Focused on Gene Synthesis and Tools.....II-61
454 Life Sciences (US).....II-61
Agilent Technologies Inc. (US).....II-61
1$100
   ATG Biosynthetics GmbH (Germany).....II-62
DNA2.0 (US).....II-62
1$100
   Epoch Life Science, Inc. (US.....II-63
Gen9 Inc (US).....II-63
1$100
   GenScript USA, Inc. (US).....II-64
Gingko Bioworks Inc (US).....II-64
1$100
   Intrexon Corporation (US).....II-65
LC Sciences LLC (US).....II-65
Life Technologies Corp. (US).....II-65
1$100
   OPXBIO Inc......II-66
OriGene Technologies, Inc......II-66
1$100
   Sangamo BioSciences, Inc. (US).....II-67
Verdezyne, Inc......II-67
1$100
   Table 4: World Recent Past, Current & Future Analysis for Synthetic Biology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2010 through 2018 (includes corresponding Graph/Chart).....II-681$350
   Table 5: World Historic Review for Synthetic Biology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2004 through 2009 (includes corresponding Graph/Chart).....II-691$350
   Table 6: World 15-Year Perspective for Synthetic Biology by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart).....II-701$350
   Table 7: World Recent Past, Current & Future Analysis for Synthetic Biology by End-Use Sector - Energy & Chemicals, Biotechnology & Pharmaceuticals, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2010 through 2018 (includes corresponding Graph/Chart).....II-711$350
   Table 8: World Historic Review for Synthetic Biology by End-Use Sector - Energy & Chemicals, Biotechnology & Pharmaceuticals, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2004 through 2009 (includes corresponding Graph/Chart).....II-721$350
   Table 9: World 15-Year Perspective for Synthetic Biology by End-Use Sector - Percentage Breakdown of Dollar Sales for Energy & Chemicals, Biotechnology & Pharmaceuticals, and Others Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart).....II-731$350
   A. Market Analysis.....III-1
Current & Future Analysis.....III-1
Research in the US.....III-1
Table 10: Number of Entities Focused on Synthetic Biology Research in the US (2009 & 2013) (includes corresponding Graph/Chart).....III-1
1$200
   International Genetically Engineered Machine (IGEM) – A Platform for
  Innovations.....III-2
Product Launches.....III-2
2$150
   Strategic Corporate Developments.....III-411$495
   Key Players.....III-1510$395
   B. Market Analytics.....III-25
Table 11: US Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-25

Table 12: US Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-25
1$200
   A. Market Analysis.....III-26
Current & Future Analysis.....III-26
B. Market Analytics.....III-26
Table 13: Canadian Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-26
1$200
   Table 14: Canadian Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-271$200
   A. Market Analysis.....III-28
Current & Future Analysis.....III-28
B. Market Analytics.....III-28
Table 15: Japanese Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-28
1$200
   Table 16: Japanese Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-291$200
   A. Market Analysis.....III-30
Current & Future Analysis.....III-30
Research in Europe.....III-30
1$75
   Table 17: Number of Entities Focused on Synthetic Biology Research in Europe (2009 & 2013) (includes corresponding Graph/Chart).....III-311$200
   B. Market Analytics.....III-32
Table 18: European Recent Past, Current & Future Analysis for Synthetic Biology by Geographic Region - France, Germany, Italy, UK, Spain and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-32
1$200
   Table 19: European Historic Review for Synthetic Biology by Geographic Region - France, Germany, Italy, UK, Spain and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-331$200
   Table 20: European 15-Year Perspective for Synthetic Biology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain and Rest of Europe Markets for Years 2004, 2013 & 2018 (includes corresponding Graph/Chart).....III-341$200
   A. Market Analysis.....III-35
Current & Future Analysis.....III-35
Strategic Corporate Development.....III-35
1$75
   B. Market Analytics.....III-36
Table 21: French Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-36

Table 22: French Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-36
1$200
   A. Market Analysis.....III-37
Current & Future Analysis.....III-37
Strategic Corporate Development.....III-37
Key Players.....III-37
1$75
   B. Market Analytics.....III-38
Table 23: German Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-38
1$200
   Table 24: German Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-391$200
   A. Market Analysis.....III-40
Current & Future Analysis.....III-40
B. Market Analytics.....III-40
Table 25: Italian Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-40
1$200
   Table 26: Italian Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-411$200
   A. Market Analysis.....III-42
Current & Future Analysis.....III-42
Market Overview.....III-42
UK Government Awards Over £6 Million Grant for Synthetic Biology.....III-42
1$75
   UK Government Funding for Synthetic Biology: 2013.....III-43
SynbiCITE Centre to Spearhead UK Research in Synthetic Biology.....III-43
BP PLC. - A Key Player.....III-43
1$75
   B. Market Analytics.....III-44
Table 27: UK Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-44
1$200
   Table 28: UK Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-451$200
   A. Market Analysis.....III-46
Current & Future Analysis.....III-46
B. Market Analytics.....III-46
Table 29: Spanish Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-46
1$200
   Table 30: Spanish Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-471$200
   A. Market Analysis.....III-48
Current & Future Analysis.....III-48
Strategic Corporate Development.....III-48
Evolva SA (Switzerland) – A Major Player.....III-48
1$75
   B. Market Analytics.....III-49
Table 31: Rest of Europe Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-49
1$200
   Table 32: Rest of Europe Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-501$200
   A. Market Analysis.....III-51
Current & Future Analysis.....III-51
Table 33: Number of Entities Focused on Synthetic Biology Research in Asia and Oceania in 2013 (includes corresponding Graph/Chart).....III-51
B. Market Analytics.....III-51
Table 34: Asia-Pacific Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-51
1$200
   Table 35: Asia-Pacific Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-521$200
   A. Market Analysis.....III-53
Current & Future Analysis.....III-53
Strategic Corporate Development.....III-53
B. Market Analytics.....III-53
Table 36: Rest of World Recent Past, Current & Future Analysis for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-53
1$200
   Table 37: Rest of World Historic Review for Synthetic Biology Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-541$200
  
Total Companies Profiled: 38 (including Divisions/Subsidiaries - 39)

Region/Country Players

The United States 30 Canada 1 Europe 6 France 1 Germany 3 The United Kingdom 1 Rest of Europe 1 Asia-Pacific (Excluding Japan) 2
Click here to request a full table of contents and more details on this project.